GLAPF Stock Chart & Stats
$20.08
-$1.20(-7.97%)
At close: 4:00 PM EST
$20.08
-$1.20(-7.97%)
Day’s Range― - ―
52-Week Range$13.49 - $28.81
Previous CloseN/A
Volume862.00
Average Volume (3M)207.00
Market Cap
$6.64B
Enterprise Value$3.98B
Total Cash (Recent Filing)$280.89M
Total Debt (Recent Filing)$982.14M
Price to Earnings (P/E)37.7
Beta0.45
Next Earnings
Aug 06, 2026EPS Estimate
0.7Next Dividend Ex-DateN/A
Dividend Yield2.65%
Share Statistics
EPS (TTM)0.50
Shares Outstanding239,298,370
10 Day Avg. Volume400
30 Day Avg. Volume207
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.60
Enterprise Value/Revenue2.36
Enterprise Value/Gross Profit7.08
Enterprise Value/Ebitda17.01
Forecast
1Y Price Target
$25.52Price Target Upside27.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Glanbia News
GLAPF FAQ
What was Glanbia Plc’s price range in the past 12 months?
Glanbia Plc lowest stock price was $13.49 and its highest was $28.81 in the past 12 months.
What is Glanbia Plc’s market cap?
Glanbia Plc’s market cap is $6.64B.
When is Glanbia Plc’s upcoming earnings report date?
Glanbia Plc’s upcoming earnings report date is Aug 06, 2026 which is in 36 days.
How were Glanbia Plc’s earnings last quarter?
Glanbia Plc released its earnings results on Feb 25, 2026. The company reported $0.719 earnings per share for the quarter, beating the consensus estimate of $0.696 by $0.023.
Is Glanbia Plc overvalued?
According to Wall Street analysts Glanbia Plc’s price is currently Undervalued.
Does Glanbia Plc pay dividends?
Glanbia Plc pays a Semiannually dividend of $0.296 which represents an annual dividend yield of 2.65%. See more information on Glanbia Plc dividends here
What is Glanbia Plc’s EPS estimate?
Glanbia Plc’s EPS estimate is 0.7.
How many shares outstanding does Glanbia Plc have?
Glanbia Plc has 239,298,370 shares outstanding.
What happened to Glanbia Plc’s price movement after its last earnings report?
Glanbia Plc reported an EPS of $0.719 in its last earnings report, beating expectations of $0.696. Following the earnings report the stock price went up 3.341%.
Which hedge fund is a major shareholder of Glanbia Plc?
Currently, no hedge funds are holding shares in GLAPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glanbia Plc
Operating globally as a prominent nutrition company, Glanbia plc specializes in the development and distribution of sports and lifestyle nutrition products. These offerings come in various forms, including powdered supplements, ready-to-eat bars, convenient snacking foods, and prepared beverages. The company reaches consumers through a wide array of distribution channels, encompassing specialty retailers, online platforms, fitness centers, and larger retail environments such as food, drug, mass-market, and club stores. Additionally, Glanbia is a key producer of cheese, a diverse range of dairy and non-dairy nutritional and functional ingredients, and vital vitamin and mineral premixes. Its operational scope extends beyond product manufacturing to include activities such as financing, research and development, property management, receivables handling, general business administration, property leasing, various business services, and weight management solutions. The company boasts a robust portfolio of renowned brands, including OPTIMUM NUTRITION, SlimFast, BSN, ISOPURE, NUTRAMINO, think!, Amazing Grass, and BODY&FIT. Glanbia plc was founded in 1964 and maintains its corporate headquarters in Kilkenny, Ireland.
GLAPF Company Deck
GLAPF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presents a balanced picture: robust top-line growth, strong cash generation, active shareholder returns, and clear strategic progress (notably in Health & Nutrition, Optimum Nutrition momentum, M&A and capacity expansion). These positives are materially offset by significant margin pressure in Performance Nutrition driven by record whey input costs, a marked decline in PN EBITDA, sizeable exceptional charges related to transformation and disposals, and near-term cost/price lags that will affect 2026 results. Management has contracts in place for whey supply, is implementing further pricing, and expects margin recovery over the medium term supported by the transformation savings and capacity investments, but near-term execution and elevated input costs keep the outlook mixed.View all GLAPF earnings summariesGLAPF Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$25.52
▲(27.09% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
14.49% Insiders
6.05% Mutual Funds
― Other Institutional Investors
73.93% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---







